RADWARE LTD. (Exact Name of Registrant As Specified in Its Charter)

Total Page:16

File Type:pdf, Size:1020Kb

RADWARE LTD. (Exact Name of Registrant As Specified in Its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ OR o SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report _________ Commission file number: 0-30324 RADWARE LTD. (Exact name of registrant as specified in its charter) Israel (Jurisdiction of incorporation or organization) 22 Raoul Wallenberg Street, Tel Aviv 69710, Israel (Address of principal executive offices) Gadi Meroz, Adv. General Counsel Tel. +972-3-7668666, Fax: +972-3-7668982 22 Raoul Wallenberg St., Tel Aviv 69710, Israel (Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Ordinary Shares, The Nasdaq Stock Market LLC NIS 0.05 par value per share Securities registered or to be registered pursuant to Section 12(g) of the Act: None (Title of Class) Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report (December 31, 2014): 46,926,497 Ordinary Shares, NIS 0.05 par value per share Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. oYes ⌧ No If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. oYes ⌧ No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ⌧Yes o No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ⌧Yes o No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. Large Accelerated Filer o Accelerated Filer ⌧ Non-Accelerated Filero Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing: ⌧ U.S. GAAP o International Financial Reporting Standards as issued by the International Accounting Standards Board o Other If “Other” has been checked in response to the previous question indicate by check mark which financial statement item the registrant has elected to follow: oItem 17 o Item 18 If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). oYes ⌧ No - 2 - INTRODUCTION Unless the context otherwise requires, all references in this annual report to: • “we,” “us,” “our,” the “Company,” and “Radware” are to Radware Ltd. and its subsidiaries; • “ordinary shares” are to our Ordinary Shares, par value NIS 0.05 per share; • “Companies Law” or the “Israeli Companies Law” are to the Israeli Companies Law, 5759-1999, as amended; • the “SEC” are to the U.S. Securities and Exchange Commission; • “U.S. GAAP” are to generally accepted accounting principles in the United States; • “NASDAQ” are to the NASDAQ Global Market (formerly, the Nasdaq National Market); • “dollars”, “$” or “US$” are to U.S. dollars; and • “NIS” or “shekels” are to New Israeli Shekels. We have registered trademarks for, among others, “Radware®”, Radware’s design logo appearing in the cover page of this annual report, “APSolute®”, “Web Server Director®”, “FireProof®”, “LinkProof®”, “Triangulation®”, “Smart Nat®”, “DefensePro®”, “StringMatch Engine®”, “CID®”, “CID – Content Inspection Director®”, “SIPDirector®”, “AppDirector®”, “AppXcel®”, “AppXML®”, “SecureFlow®”, “OnDemand Switch®”, “AppWall®”, “Apsolute Insite®”, “APSolute Vision®”, “vAdapter®”, “VADI®”, “FastView®”, “Alteon®”, “ALTEON VA®”, “SmartNat®”, “vDirect®”, “Radware ADC Fabric®” “AppShape®”, “TeraVIP®”, “DefenseFlow®” and we have trademark applications pending for, among others, “Virtual Director™”, “ADC Fabric™”, “DefensePipe™”, “ADC-VX”™ and “Inflight”™. Unless the context otherwise indicates, all other trademarks and trade names appearing in this annual report are owned by their respective holders. Our consolidated financial statements appearing in this annual report are prepared in dollars and in accordance with U.S. GAAP, and are audited in accordance with the standards of the Public Company Accounting Oversight Board in the United States. On April12, 2015, the exchange rate between the NIS and the dollar, as quoted by the Bank of Israel, was NIS 3.938 to $1.00. Unless the context otherwise indicates, statements in this annual report that provide the dollar equivalent of NIS amounts or provide the NIS equivalent of dollar amounts are based on such exchange rate. On April 12, 2013, we effected a two-for-one forward split of our ordinary shares, and accordingly the par value of our ordinary shares has changed from NIS 0.1 to NIS 0.05 per share. Unless indicated otherwise by the context, all ordinary shares, options and per share amounts as well as stock prices in this annual report have been adjusted to give retroactive effect to the stock split for all periods presented. Statements made in this annual report concerning the contents of any contract, agreement or other document are summaries of such contracts, agreements or documents and are not complete descriptions of all of their terms. If we filed any of these documents as an exhibit to this annual report or to any registration statement or annual report that we previously filed, you may read the document itself for a complete description of its terms, and the summary included herein is qualified by reference to the full text of the document which is incorporated by reference into this annual report. - 3 - CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Except for the historical information contained herein, the statements contained in this annual report are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our business, financial condition and results of operations. Actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including all the risks discussed in “Risk Factors” and elsewhere in this annual report. We urge you to consider that statements which use the terms “believe,” “do not believe,” “expect,” “plan,” “intend,” “estimate,” “anticipate,” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements appear in Item 3.D “Risk Factors”, Item 4 “Information on the Company”, and Item 5 “Operating and Financial Review and Prospects” as well as elsewhere in this annual report. These statements reflect our current views with respect to future events and are based on assumptions and are subject to risks and uncertainties, including those discussed under Item 3.D “Risk Factors” and in our other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by applicable law, including the securities laws of the United States, we do not intend to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. - 4 - Table of Contents PART I 7 ITEM 1. Identity of Directors, Senior Management and Advisers 7 ITEM 2. Offer Statistics and Expected Timetable 7 ITEM 3. Key Information 8 A. Selected Financial Data 8 B. Capitalization and Indebtedness 9 C. Reasons for the Offer and Use of Proceeds 9 D. Risk Factors 9 ITEM 4. Information on the Company 25 A. History and Development of the Company 25 B. Business Overview 25 C. Organizational Structure 39 D. Property, Plants and Equipment 40 ITEM 4A. UNRESOLVED STAFF COMMENTS 41 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 41 A. Operating Results 41 B. Liquidity and Capital Resources 53 C. Research and Development, Patents and Licenses, etc. 56 D. Trend Information 56 E. Off-Balance Sheet Arrangements 56 F. Tabular Disclosure of Contractual Obligations 56 ITEM 6. Directors, Senior Management and Employees 58 A. Directors and Senior Management 58 B. Compensation 60 C. Board Practices 63 D. Employees 70 E. Share Ownership 71 ITEM 7. Major Shareholders and Related Party Transactions 74 A. Major Shareholders 74 B. Related Party Transactions 75 C. Interests of Experts and Counsel 77 ITEM 8. Financial Information 78 A. Consolidated Statements and other Financial Information 78 B. Significant Changes 79 - 5 - ITEM 9. The Offer and Listing 80 A. Offer and Listing Details 80 B. Plan of Distribution 81 C. Markets 81 D. Selling Shareholders 81 E. Dilution 81 F.
Recommended publications
  • Alphabetical Listing by Company Name
    FOREIGN COMPANIES REGISTERED AND REPORTING WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION December 31, 2015 Alphabetical Listing by Company Name COMPANY COUNTRY MARKET 21 Vianet Group Inc. Cayman Islands Global Market 37 Capital Inc. Canada OTC 500.com Ltd. Cayman Islands NYSE 51Job, Inc. Cayman Islands Global Market 58.com Inc. Cayman Islands NYSE ABB Ltd. Switzerland NYSE Abbey National Treasury Services plc United Kingdom NYSE - Debt Abengoa S.A. Spain Global Market Abengoa Yield Ltd. United Kingdom Global Market Acasti Pharma Inc. Canada Capital Market Acorn International, Inc. Cayman Islands NYSE Actions Semiconductor Co. Ltd. Cayman Islands Global Market Adaptimmune Ltd. United Kingdom Global Market Adecoagro S.A. Luxembourg NYSE Adira Energy Ltd. Canada OTC Advanced Accelerator Applications SA France Global Market Advanced Semiconductor Engineering, Inc. Taiwan NYSE Advantage Oil & Gas Ltd. Canada NYSE Advantest Corp. Japan NYSE Aegean Marine Petroleum Network Inc. Marshall Islands NYSE AEGON N.V. Netherlands NYSE AerCap Holdings N.V. Netherlands NYSE Aeterna Zentaris Inc. Canada Capital Market Affimed N.V. Netherlands Global Market Agave Silver Corp. Canada OTC Agnico Eagle Mines Ltd. Canada NYSE Agria Corp. Cayman Islands NYSE Agrium Inc. Canada NYSE AirMedia Group Inc. Cayman Islands Global Market Aixtron SE Germany Global Market Alamos Gold Inc. Canada NYSE Alcatel-Lucent France NYSE Alcobra Ltd. Israel Global Market Alexandra Capital Corp. Canada OTC Alexco Resource Corp. Canada NYSE MKT Algae Dynamics Corp. Canada OTC Algonquin Power & Utilities Corp. Canada OTC Alianza Minerals Ltd. Canada OTC Alibaba Group Holding Ltd. Cayman Islands NYSE Allot Communications Ltd. Israel Global Market Almaden Minerals Ltd.
    [Show full text]
  • AI Powered International Equity ETF Schedule of Investments August 31, 2020 (Unaudited)
    AI Powered International Equity ETF Schedule of Investments August 31, 2020 (Unaudited) Shares Security Description Value COMMON STOCKS - 99.4% Argentina - 1.1% 360 Globant SA (a) $ 63,929 Australia - 3.3% 512 Atlassian Corporation plc - Class A (a) 98,182 700 Australia & New Zealand Banking Group, Ltd. - ADR 9,463 3,684 Mesoblast, Ltd. - ADR (a) 71,323 1,568 National Australia Bank, Ltd. - ADR 10,396 189,364 Belgium - 1.5% 233 Galapagos NV - ADR (a) 31,026 1,375 Materialise NV - ADR (a) 55,908 86,934 Canada - 38.0% 7,200 Alexco Resource Corporation (a) 22,248 1,089 Algonquin Power & Utilities Corporation 15,061 914 Aurinia Pharmaceuticals, Inc. (a) 13,555 12,605 Auryn Resources, Inc. (a) 24,580 1,140 B2Gold Corporation 7,684 2,052 Ballard Power Systems, Inc. (a) 34,063 1,650 Barrick Gold Corporation 48,923 132 BCE, Inc. 5,677 4,774 BlackBerry, Ltd. (a) 24,920 748 Brookfield Asset Management, Inc. - Class A 25,238 1,049 CAE, Inc. (a) 16,585 376 Canada Goose Holdings, Inc. (a) 9,208 462 Canadian National Railway Company 48,316 1,963 Canadian Natural Resources, Ltd. 38,612 146 Canadian Pacific Railway, Ltd. 43,169 1,491 Canadian Solar, Inc. (a) 48,443 1,635 Canopy Growth Corporation (a) 26,963 840 Canopy Growth Corporation (a) 13,877 2,220 Cascades, Inc. 23,607 2,744 Celestica, Inc. (a) 21,815 11 Constellation Software, Inc. 12,734 1,064 Descartes Systems Group, Inc. (a) 64,851 2,039 Dollarama, Inc. 79,600 1,597 Eldorado Gold Corporation (a) 18,238 13,136 EMX Royalty Corporation (a) 38,357 17,174 Enerplus Corporation 45,511 1,337 Fortis, Inc.
    [Show full text]
  • Ceragon Networks Ltd. Notice of 2018 Annual General Meeting of Shareholders ___
    CERAGON NETWORKS LTD. ___________________________________________ NOTICE OF 2018 ANNUAL GENERAL MEETING OF SHAREHOLDERS ___________________________________________ TO BE HELD ON JUNE 12, 2018 Notice is hereby given that the 2018 Annual General Meeting of Shareholders (the “Meeting”) of Ceragon Networks Ltd. (the “Company”) will be held on Tuesday, June 12, 2018 at 5:00 p.m. (Israel time), at the offices of the Company, 24 Raoul Wallenberg Street, Tel Aviv, Israel, for the following purposes: 1. To re-elect Zohar Zisapel, Yael Langer and Shlomo Liran, and to elect Ira Palti, our President and CEO, and Avi Eizenman, to serve on the Board of Directors of the Company and to approve a grant of options to each of them (except for Mr. Palti), as part of their consideration for service as directors; 2. To elect Avi Berger and Meir Sperling to serve on the Board of Directors of the Company as external directors, and to approve a grant of options to each of them, as part of their consideration for service as external directors; 3. To approve amendments to the Company's Executives & Directors Compensation Policy; 4. To approve a cash bonus plan and equity compensation to our Chief Executive Officer for 2018; and 5. To re-appoint Kost Forer Gabbay & Kasierer, a Member of Ernst & Young Global, as the Company’s independent auditor for the fiscal year ending December 31, 2018 and until immediately following the next annual general meeting of shareholders. In the Meeting, you will also have an opportunity to receive and consider the auditor’s report and the audited consolidated financial statements of the Company for the fiscal year ended December 31, 2017.
    [Show full text]
  • ARK Invest Change to the Founds Holdings
    IZRL - Israel Innovative Technology ETF page 1 of 8 Assets that ARK invest Sold out off No new assets detected page 2 of 8 New assets that ARK invest have added to their funds No new assets detected page 3 of 8 Assets where ARK invest decrease number of shares No new assets detected page 4 of 8 Assets where ARK invest increase number of shares Compared to 04-12-2020 Date Fund Ticker Shares bought Shares bought % Company 07-12-2020 IZRL AYLA 3.750 5,28% AYALA PHARMACEUTICALS INC 07-12-2020 IZRL SSYS 3.345 4,92% STRATASYS LTD 07-12-2020 IZRL CGEN 3.039 4,67% COMPUGEN LTD 07-12-2020 IZRL PSTI 4.752 4,47% PLURISTEM THERAPEUTICS INC 07-12-2020 IZRL RADA 7.410 4,45% RADA ELECTRONIC INDS LTD 07-12-2020 IZRL FTAL 744 4,45% FATTAL HOLDINGS 1998 LTD 07-12-2020 IZRL PERI 6.441 4,44% PERION NETWORK LTD 07-12-2020 IZRL NVMI 849 4,40% NOVA MEASURING INSTRUMENTS 07-12-2020 IZRL DANE 399 4,39% DANEL (ADIR YEOSHUA) LTD 07-12-2020 IZRL BVXV 1.218 4,39% BIONDVAX PHARMACEUTICALS-ADR 07-12-2020 IZRL INMD 1.209 4,38% INMODE LTD 07-12-2020 IZRL WIX 171 4,37% WIX.COM LTD 07-12-2020 IZRL TARO 819 4,37% TARO PHARMACEUTICAL INDUS 07-12-2020 IZRL RDHL 4.872 4,37% REDHILL BIOPHARMA LTD-SP ADR 07-12-2020 IZRL MTRX 2.025 4,36% MATRIX IT LTD 07-12-2020 IZRL CRNT 19.050 4,36% CERAGON NETWORKS LTD 07-12-2020 IZRL CYBR 435 4,36% CYBERARK SOFTWARE LTD/ISRAEL 07-12-2020 IZRL CAMT 2.664 4,35% CAMTEK LTD 07-12-2020 IZRL TEVA 5.238 4,35% TEVA PHARMACEUTICAL-SP ADR 07-12-2020 IZRL HLAN 1.116 4,35% HILAN LTD 07-12-2020 IZRL AUDC 1.458 4,34% AUDIOCODES LTD 07-12-2020 IZRL ESLT
    [Show full text]
  • Bluestar Israel Equity Update First Quarter 2014
    BlueStar Israel Equity Update First Quarter 2014 Q4 2013 in Review & 2014 Outlook All major global developed market equity benchmarks rose strongly in Q4 2013 despite the announcement of the Federal Reserve’s intentions to reduce the scope of its bond purchase What’s Inside program The BlueStar Israel Global Index rose 10.54% in Q4 2013 on an annualized basis while the TA-100 and MSCI Israel indices were up 7.38% and 6.34%, respectively. The BlueStar 1. Israeli Global benchmark also outperformed the TA-100 and MSCI Israel benchmarks for the full year 2013 by 4 and 15 percentage points, respectively. Equities in Q4 2013 For the second straight quarter the rally in Israeli equities was broad based and in each of the three largest sectors: Information Technology, Financials and Health Care. Additionally a long-awaited recovery in the telecom sector took hold during the quarter. Each of these sectors rose strongly during Q4 2013 indicating strength in the domestic economy and an 2.-6. About the BIGI & acceleration in the growth rates of the economies of Israel’s largest trading partners. BIGTech Indexes, The Israeli government budget deficit continued to shrink bringing on the prospect of lower Rebalance Review, taxes and higher government spending in 2014. The labor force participation rate rose in the and Risk/Return fourth quarter while the unemployment rate remained low. Data The revival in trading volume on the TASE, rise in equity prices in most developed countries, and several relatively large IPOs by Israeli companies during the second half of 2014 resulted in a net addition of 12 companies in the BlueStar Israel Global Index’s December rebalance.
    [Show full text]
  • CERAGON NETWORKS LTD. (Exact Name of Registrant As Specified in Its Charter)
    As filed with the Securities and Exchange Commission on March 31, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report __________ Commission file number 0-30862 CERAGON NETWORKS LTD. (Exact Name of Registrant as Specified in Its Charter) Israel (Jurisdiction of Incorporation or Organization) 24 Raoul Wallenberg Street, Tel Aviv 69719, Israel (Address of Principal Executive Offices) Zvi Maayan (+972) 3-543-1643 (tel.), (+972) 3-543-1600 (fax), 24 Raoul Wallenberg Street, Tel Aviv 6971920, Israel (Name, Telephone, E-mail and/or Facsimile Number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Ordinary Shares, Par Value NIS 0.01 CRNT Nasdaq Global Select Market Securities registered or to be registered pursuant to Section 12(g) of the Act: None Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report 80,662,805 Ordinary Shares, NIS 0.01 par value.
    [Show full text]
  • RADWARE LTD. (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ OR o SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report _________ Commission file number 0-30324 RADWARE LTD. (Exact name of registrant as specified in its charter) Israel (Jurisdiction of incorporation or organization) 22 Raoul Wallenberg Street, Tel Aviv 69710, Israel (Address of principal executive offices) Gadi Meroz, Adv. General Counsel Tel. +972-3-7668666, Fax: +972-3-7668982 22 Raoul Wallenberg St., Tel Aviv 69710, Israel (Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Ordinary Shares, The Nasdaq Stock Market LLC NIS 0.1 par value per share Securities registered or to be registered pursuant to Section 12(g) of the Act: None (Title of Class) Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report (December 31, 2012): 22,185,452 Ordinary Shares, NIS 0.1 par value per share Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
    [Show full text]
  • CERAGON NETWORKS LTD. (Exact Name of Registrant As Specified in Its Charter) ______
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number 0-30862 _________________________ CERAGON NETWORKS LTD. (Exact Name of Registrant as Specified in Its Charter) _______________________ Israel (Jurisdiction of Incorporation or Organization) 24 Raoul Wallenberg Street, Tel Aviv 69719, Israel (Address of Principal Executive Offices) Michal Lavee Machlav (+972) 3-543-1284 (tel.), (+972) 3-543-1600 (fax), 24 Raoul Wallenberg Street, Tel Aviv 69719, Israel (Name, Telephone, E-mail and/or Facsimile Number and Address of Company Contact Person) ________________________ Securities registered or to be registered pursuant to Section 12(b) of the Act: Title of Each Class Name of Exchange of Which Registered Ordinary Shares, Par Value NIS 0.01 Nasdaq Global Select Market Securities registered or to be registered pursuant to Section 12(g) of the Act: None Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report 78,045,192 Ordinary Shares, NIS 0.01 par value.
    [Show full text]
  • Compugen: Rising Bioinformatics Star
    October 2000 No. 53 The #1 investment newsletter on Israeli technology companies Compugen: Rising bioinformatics star Compugen Ltd. analysis and modeling processes. Its technologies $ Nasdaq enable scientists to accelerate their research efforts (based on daily closing prices) in discovery of drugs, therapeutics, diagnostics and 20 agricultural products. 18 The field of predicting biological processes through 16 the use of mathematics has generated intense 14 interest, particularly since the advent of the Human 12 Genome Project, which created huge amounts of raw genomic and other data. The underlying biology is 10 IPO price complex, and the data are relatively unorganized, rife with errors, overlaps, duplication and missing pieces. Trading Volume, in millions These factors have made Genome Project data 0.6 exceedingly difficult to analyze. 0.4 But the potential for using this data is immense 0.2 since many human diseases are related to inadequate or poorly performing proteins. Aug 15 Sept 1 Sept 15 Thousands of additional drug targets and possible Traded: Nasdaq Symbol: CGEN cures for diseases, rather than just treatments, may Recent Price: $14 1/16 be identified through a better understanding of how 2000 High - Low: $19 1/2 - $10 1/16 proteins are regulated, inhibited or stimulated and Initial Offering Price: $10 the genetic content of cells. Shares Offered: 5,000,000 continued on page 2 Shares Outstanding: 25,975,581 Market Capitalization: $365 million In This Issue... Formed in 1993, Compugen has made a name for Compugen: Rising bioinformatics star 1 itself as a pioneer in combining advanced The Market 4 computational techniques and molecular biology.
    [Show full text]
  • Ark ETF Trust Form NPORT-P Filed 2021-06-24
    SECURITIES AND EXCHANGE COMMISSION FORM NPORT-P Filing Date: 2021-06-24 | Period of Report: 2021-04-30 SEC Accession No. 0001752724-21-135185 (HTML Version on secdatabase.com) FILER Ark ETF Trust Mailing Address Business Address 155 WEST 19TH STREET, 155 WEST 19TH STREET, CIK:1579982| IRS No.: 000000000 | State of Incorp.:DE | Fiscal Year End: 0831 FIFTH FLOOR FIFTH FLOOR Type: NPORT-P | Act: 40 | File No.: 811-22883 | Film No.: 211042006 NEW YORK NY 10011 NEW YORK NY 10011 212.426.7040 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Schedule of Investments The ARK Israel Innovative Technology ETF April 30, 2021 (Unaudited) Investments Shares Value COMMON STOCKS–99.6% Aerospace & Defense - 5.3% Bet Shemesh Engines Holdings 1997 Ltd. (Israel)* 277,110 $ 6,172,028 Elbit Systems Ltd. (Israel) 42,187 5,803,984 RADA Electronic Industries Ltd. (Israel)* 456,837 6,025,680 Total Aerospace & Defense 18,001,692 Biotechnology - 9.3% Enlivex Therapeutics Ltd. (Israel)* 553,857 6,336,124 Evogene Ltd. (Israel)* 918,734 4,146,302 Gamida Cell Ltd. (Israel)* 741,409 5,471,598 Kamada Ltd. (Israel)* 984,509 6,013,102 Pluristem Therapeutics, Inc.* 716,911 3,039,703 UroGen Pharma Ltd.* 340,231 6,617,493 Total Biotechnology 31,624,322 Communications Equipment - 12.2% AudioCodes Ltd. (Israel) 193,493 5,961,519 BATM Advanced Communications Ltd. (Israel)* 4,613,301 6,373,850 Ceragon Networks Ltd. (Israel)* 1,643,363 5,603,868 Gilat Satellite Networks Ltd. (Israel) 598,069 6,010,594 Ituran Location and Control Ltd.
    [Show full text]
  • Form 20-F Radware Ltd
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ OR o SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report _________ Commission file number 0-30324 RADWARE LTD. (Exact name of registrant as specified in its charter) Israel (Jurisdiction of incorporation or organization) 22 Raoul Wallenberg Street, Tel Aviv 69710, Israel (Address of principal executive offices) Gadi Meroz, Adv. General Counsel Tel. +972-3-7668666, Fax: +972-3-7668982 22 Raoul Wallenberg St., Tel Aviv 69710, Israel (Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Ordinary Shares, The Nasdaq Stock Market LLC NIS 0.1 par value per share Securities registered or to be registered pursuant to Section 12(g) of the Act: None (Title of Class) Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report (December 31, 2011): 21,250,300 Ordinary Shares, NIS 0.1 par value per share Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
    [Show full text]
  • Ishares, Inc. Form NPORT-P Filed 2021-07-28
    SECURITIES AND EXCHANGE COMMISSION FORM NPORT-P Filing Date: 2021-07-28 | Period of Report: 2021-05-31 SEC Accession No. 0001752724-21-158980 (HTML Version on secdatabase.com) FILER iShares, Inc. Mailing Address Business Address 400 HOWARD STREET 400 HOWARD STREET CIK:930667| IRS No.: 510396525 | State of Incorp.:MD | Fiscal Year End: 0831 SAN FRANCISCO CA 94105 SAN FRANCISCO CA 94105 Type: NPORT-P | Act: 40 | File No.: 811-09102 | Film No.: 211121021 (415) 670-2000 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Schedule of Investments (unaudited) iShares® MSCI Israel ETF May 31, 2021 (Percentages shown are based on Net Assets) Security Shares Value Common Stocks Aerospace & Defense — 1.9% Elbit Systems Ltd. 22,765 $ 2,965,411 Banks — 17.8% Bank Hapoalim BM(a) 974,893 8,268,190 Bank Leumi Le-Israel BM(a) 1,247,382 9,752,765 FIBI Holdings Ltd.(a) 15,257 565,012 First International Bank of Israel Ltd.(a) 47,619 1,517,002 Israel Discount Bank Ltd., Class A(a) 999,366 4,965,833 Mizrahi Tefahot Bank Ltd.(a) 120,440 3,584,872 28,653,674 Biotechnology — 0.2% UroGen Pharma Ltd.(a) 16,569 291,946 Building Products — 0.2% Caesarstone Ltd. 20,747 342,325 Capital Markets — 0.4% Altshuler Shaham Provident Funds & Pension 49,494 348,938 Ltd. Electreon Wireless Ltd.(a) 3,739 317,431 666,369 Chemicals — 3.4% ICL Group Ltd. 604,773 4,366,088 Israel Corp. Ltd. (The)(a) 3,313 1,032,313 5,398,401 Communications Equipment — 1.5% AudioCodes Ltd.
    [Show full text]